These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30841928)

  • 1. Complications of diabetes in China: health system and economic implications.
    Mao W; Yip CW; Chen W
    BMC Public Health; 2019 Mar; 19(1):269. PubMed ID: 30841928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    J Diabetes Investig; 2019 Mar; 10(2):531-538. PubMed ID: 29993198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?
    Wang W; Fu CW; Pan CY; Chen W; Zhan S; Luan R; Tan A; Liu Z; Xu B
    Value Health; 2009 Sep; 12(6):923-9. PubMed ID: 19824187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical care expenditures for diabetes, its chronic complications, and its comorbidities.
    Hodgson TA; Cohen AJ
    Prev Med; 1999 Sep; 29(3):173-86. PubMed ID: 10479605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China.
    Chen D; Liu S; Tan X; Zhao Q
    BMC Health Serv Res; 2017 Mar; 17(1):199. PubMed ID: 28288623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China.
    Zhu D; Shi X; Nicholas S; Ma Y; He P
    Cancer Med; 2021 Apr; 10(8):2914-2923. PubMed ID: 33749141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
    Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.
    Guy GP; Yabroff KR; Ekwueme DU; Rim SH; Li R; Richardson LC
    J Clin Oncol; 2017 Jun; 35(18):2053-2061. PubMed ID: 28471724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the separating of hospital revenue from drug sales reduce the burden on patients? Evidence from China.
    Li L; Yu Q
    Int J Equity Health; 2021 Jan; 20(1):12. PubMed ID: 33407503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial protection of rural health insurance for patients with hypertension and diabetes: repeated cross-sectional surveys in rural China.
    Liu X; Sun X; Zhao Y; Meng Q
    BMC Health Serv Res; 2016 Sep; 16(1):481. PubMed ID: 27608976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
    Siegel KR; Ali MK; Zhou X; Ng BP; Jawanda S; Proia K; Zhang X; Gregg EW; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1557-1592. PubMed ID: 33534729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).
    Lugo-Palacios DG; Cairns J; Masetto C
    BMC Health Serv Res; 2016 Aug; 16():333. PubMed ID: 27484124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.
    Barquera S; Campos-Nonato I; Aguilar-Salinas C; Lopez-Ridaura R; Arredondo A; Rivera-Dommarco J
    Global Health; 2013 Feb; 9():3. PubMed ID: 23374611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental treatment expenditure of diabetes in the United States.
    Balu S
    Manag Care Interface; 2007 Apr; 20(4):20-7. PubMed ID: 17474327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing burden of diabetes mellitus in the US elderly population.
    Sloan FA; Bethel MA; Ruiz D; Shea AM; Feinglos MN
    Arch Intern Med; 2008 Jan; 168(2):192-9; discussion 199. PubMed ID: 18227367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.